References
- Mitchell M C, Boitnott J K, Kaufman S, Cameron J L, Maddrey W C. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine 1982; 61: 199–218
- Cohen J, Edelman R R, Chopra S. Portal vein thrombosis: a review. Am J Med 1992; 92: 173–82
- Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. Ann Intern Med 1985; 103: 329–34
- Valla D, Casadevall N, Huisse M G, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 1988; 94: 1063–9
- Pagluica A, Mufti G M, Janossa-Tahernia M, et al. In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis. Possible evidence of an occult myeloproliferative state. O J Med 1990; 76: 981–9
- Teofili L, De Stefano V, Leone G, et al. Hematological causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis. Thromb Haemost 1992; 67: 297–301
- Iscovc N, Sieber F, Winterholter K. Erythroid colony formation in culture of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography in agarose-concanavalin A. J Cell Physiol 1974; 83: 309–20
- Powell-Jackson P R, Melia W, Canalese J, Pickford R B, Port-Mann B, Williams R. Budd-Chiari syndrome: clinical patterns and therapy. Q J Med 1982; 51: 79–88
- Ludwig J, Hashimoto E, McGill D B, Van Heerden J A. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990; 65: 51–5
- Webb L J, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979; 48: 627–39
- Cardin F, Graffeo M, McCormick P A, McIntyre N, Burroughs A. Adult ‘idiopathic’ extrahepatic venous thrombosis. Importance of putative ‘latent’ myeloproliferative disorders and comparison with cases with known etiology. Dig Dis Sci 1992; 37: 335–9
- Lemoine F, Najman A, Baillou C, et al. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood 1986; 68: 996–1002
- Pearson T C, Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet 1978; ii: 1219–22
- Berk P D, Goldberg D, Donovan P B, Fruchtman S M, Berlin N I, Wasserman L R. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986; 23: 132–43
- Goldstein R, Clark P, Klintmalm G, Husberg B, Gonwa T, Stone M. Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: treatment with hydroxyurea and aspirin. Transplant Proc 1991; 23: 1559–60
- Tartaglia A P, Goldberg J D, Berk P D, Wasserman L R. Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol 1986; 23: 172–6